Loading clinical trials...
Loading clinical trials...
This is a clinical trial study that aims to evaluate the specificity of the relationship between reduced sensitivity to social reward and social anhedonia at both behavioral and neural levels. Individ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Alabama at Birmingham
Collaborators
NCT07645443 · Early Onset Psychosis, First Psychotic Episode Within the Last 5 Years, and more
NCT07029581 · Lewy Body Dementia Psychosis
NCT07226895 · Clinical High Risk for Psychosis (CHR)
NCT06159673 · Alzheimer's Disease Psychosis
NCT06740383 · Schizophrenia Spectrum and Other Psychotic Disorders, Schizophrenia, and more
University of Alabama at Birmingham
Birmingham, Alabama
University of California Los Angeles
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions